Skip to main content
logo
Genomic Valley Biotech Limited (BOM:539206)
India flag India · Delayed Price · Currency is INR
30.40
-0.09 (-0.30%)
At close: Aug 21, 2026

Genomic Valley Biotech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
2.162.688.441.6527.230.71
Revenue Growth
-72.32%-68.30%411.25%-93.94%3758.23%-66.09%
Gross Profit
2.162.686.421.6511.370.68
Operating Income
0.30.44.370.148.71-4.56
Net Income
0.20.33.560.156.48-0.09
Earnings Per Share
0.070.101.170.052.12-0.03
EPS Growth
-91.82%-91.45%2240.00%-97.64%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.260.260.450.060.410.03
Total Debt
------
Net Cash (Debt)
0.260.260.450.060.410.03
Net Cash Growth
-42.01%-42.01%644.62%-85.30%1441.91%-
Net Cash Per Share
0.090.090.150.020.140.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--0.190.27-0.2-7.79-21.29
Capital Expenditures
---0.09---
Free Cash Flow
--0.190.18-0.2-7.79-21.29
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%76.08%99.78%41.75%96.53%
Operating Margin
13.92%14.97%51.78%8.56%31.99%-646.85%
Pretax Margin
13.92%14.97%52.31%9.18%23.83%-2.34%
Profit Margin
9.40%11.33%42.19%9.20%23.81%-13.24%
FCF Margin
--7.10%2.09%-12.16%-28.60%-3017.82%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
458.16282.2350.26698.3510.25-
P/FCF Ratio
--1012.58---
PS Ratio
43.0931.9721.2164.232.44107.14